Home

Pfizer (PFE)

24.88
+0.34 (1.39%)
NYSE · Last Trade: Sep 6th, 7:13 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why BioNTech Stock Crushed the Market Todayfool.com
The company might be close to commercializing its most advanced pipeline program.
Via The Motley Fool · September 5, 2025
Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?investors.com
It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.
Via Investor's Business Daily · September 5, 2025
Down 34%, Should You Buy the Dip on Viking Therapeutics?fool.com
Viking aims to enter the billion-dollar weight loss drug market.
Via The Motley Fool · September 5, 2025
Robert F. Kennedy Took Fire From Both Republicans And Democrats Over Vaccine Overhauls: GOP Senators Defend Trump's Operation Warp Speedbenzinga.com
Secretary for Health and Human Services, Robert F. Kennedy Jr., faced bipartisan backlash during a combative Senate hearing on Thursday, as both Republicans and Democrats criticized his controversial vaccine policies and the abrupt firing of Centers for Disease Control and Prevention Director Susan Monarez.
Via Benzinga · September 5, 2025
Is the Market Bullish or Bearish on Pfizer?benzinga.com
Via Benzinga · September 3, 2025
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 4% Dividend Yieldsbenzinga.com
Via Benzinga · September 4, 2025
10 Stocks And ETFs 'On Sale' This Monthbenzinga.com
Via Benzinga · September 4, 2025
These S&P500 stocks are the most active in today's sessionchartmill.com
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · September 4, 2025
2 Top Dividend Stocks to Buy With Less Than $50fool.com
These stocks are cheap in more ways than one.
Via The Motley Fool · September 4, 2025
3 Things You Need to Know if You Buy Pfizer Todayfool.com
Pfizer has a lofty 6.9% dividend yield, but is it the only or best choice for investors interested in the pharma space?
Via The Motley Fool · September 4, 2025
Robert F. Kennedy Jr.'s Vaccine Shake-Up Sparks Coast-To-Coast Divide: West Coast Creates Health Alliance, Florida Rolls Back Requirementsbenzinga.com
California, Oregon and Washington form regional vaccine alliance to counter federal guidance under Robert F. Kennedy Jr. as Florida eliminates state mandates.
Via Benzinga · September 4, 2025
1 Volatile Stock on Our Buy List and 2 Facing Challenges
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
Via StockStory · September 4, 2025
Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster'benzinga.com
Florida plans to end all statewide vaccine mandates, even those required for school attendance, framing the move as a defense of individual liberties, which has since received pushback from public health experts.
Via Benzinga · September 4, 2025
Pfizer Defends Transparency On COVID-19 Vaccine Data, Says Trump’s ‘Operation Warp Speed’ Effort Deserves Nobel Peace Prizestocktwits.com
Pfizer lauded “Operation Warp Speed” for helping the country save over $1 trillion in healthcare costs due to a reduction in serious illnesses and subsequent hospitalizations.
Via Stocktwits · September 3, 2025
Curious about the most active S&P500 stocks in today's session?chartmill.com
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · September 2, 2025
Is Healthcare Setting Up to Be a Quiet Leader Into Year-End?marketbeat.com
Over $11 billion flowed into the popular healthcare sector ETF XLV in Q2 alone, suggesting smart money is positioning for a potential rebound.
Via MarketBeat · September 2, 2025
3 High-Yield Dividend Stocks You Can Buy in September and Hold Foreverfool.com
With an average yield above 6%, these stocks could do a lot to raise your passive income stream.
Via The Motley Fool · September 2, 2025
Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictionsbenzinga.com
President Donald Trump has called for pharmaceutical companies to provide evidence of the effectiveness of their COVID-19 drugs.
Via Benzinga · September 2, 2025
Pfizer's 7% Dividend: Income Gem or Value Trap?fool.com
The pharmaceutical giant currently offers a 7% yield, but dividend investors need to look beyond the headline number.
Via The Motley Fool · September 1, 2025
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Worksbenzinga.com
Daskalakis resigned due to political interference in CDC, fears harm will come from new direction. CDC leaders also resign in protest.
Via Benzinga · September 1, 2025
3 No-Brainer Stocks to Buy Right Nowfool.com
Investing in these pharmaceutical stocks is an easy decision.
Via The Motley Fool · August 31, 2025
Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepensbenzinga.com
Senator Bernie Sanders called for HHS Secretary RFK Jr.'s resignation over his anti-vaccine policies, ousting of CDC Director Susan Monarez.
Via Benzinga · August 30, 2025
4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizerfool.com
How does a 7.5% dividend yield sound?
Via The Motley Fool · August 30, 2025
Better High-Yielding Dividend Stock: Realty Income vs. Pfizerfool.com
Dividend stocks are a great way for investors to generate passive income.
Via The Motley Fool · August 30, 2025
The Great Rebalancing: Equity Markets Pivot from Tech Giants to Value and Cyclical Stocks
A significant sector rotation is currently underway in equity markets, shifting investor capital away from the mega-cap technology stocks that dominated recent years towards more traditional value and cyclical segments. This trend, gaining significant momentum in 2025, sees sectors such as financial services, basic materials, healthcare, energy, and industrials outperforming,
Via MarketMinute · August 29, 2025